Cargando…
Molecular nexopathies: a new paradigm of neurodegenerative disease
Neural networks provide candidate substrates for the spread of proteinopathies causing neurodegeneration, and emerging data suggest that macroscopic signatures of network disintegration differentiate diseases. However, how do protein abnormalities produce network signatures? The answer may lie with...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Applied Science Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794159/ https://www.ncbi.nlm.nih.gov/pubmed/23876425 http://dx.doi.org/10.1016/j.tins.2013.06.007 |
_version_ | 1782287183116238848 |
---|---|
author | Warren, Jason D. Rohrer, Jonathan D. Schott, Jonathan M. Fox, Nick C. Hardy, John Rossor, Martin N. |
author_facet | Warren, Jason D. Rohrer, Jonathan D. Schott, Jonathan M. Fox, Nick C. Hardy, John Rossor, Martin N. |
author_sort | Warren, Jason D. |
collection | PubMed |
description | Neural networks provide candidate substrates for the spread of proteinopathies causing neurodegeneration, and emerging data suggest that macroscopic signatures of network disintegration differentiate diseases. However, how do protein abnormalities produce network signatures? The answer may lie with ‘molecular nexopathies’: specific, coherent conjunctions of pathogenic protein and intrinsic network characteristics that define network signatures of neurodegenerative pathologies. Key features of the paradigm that we propose here include differential intrinsic network vulnerability to propagating protein abnormalities, in part reflecting developmental structural and functional factors; differential vulnerability of neural connection types (e.g., clustered versus distributed connections) to particular pathogenic proteins; and differential impact of molecular effects (e.g., toxic-gain-of-function versus loss-of-function) on gradients of network damage. The paradigm has implications for understanding and predicting neurodegenerative disease biology. |
format | Online Article Text |
id | pubmed-3794159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Elsevier Applied Science Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-37941592013-10-10 Molecular nexopathies: a new paradigm of neurodegenerative disease Warren, Jason D. Rohrer, Jonathan D. Schott, Jonathan M. Fox, Nick C. Hardy, John Rossor, Martin N. Trends Neurosci Opinion Neural networks provide candidate substrates for the spread of proteinopathies causing neurodegeneration, and emerging data suggest that macroscopic signatures of network disintegration differentiate diseases. However, how do protein abnormalities produce network signatures? The answer may lie with ‘molecular nexopathies’: specific, coherent conjunctions of pathogenic protein and intrinsic network characteristics that define network signatures of neurodegenerative pathologies. Key features of the paradigm that we propose here include differential intrinsic network vulnerability to propagating protein abnormalities, in part reflecting developmental structural and functional factors; differential vulnerability of neural connection types (e.g., clustered versus distributed connections) to particular pathogenic proteins; and differential impact of molecular effects (e.g., toxic-gain-of-function versus loss-of-function) on gradients of network damage. The paradigm has implications for understanding and predicting neurodegenerative disease biology. Elsevier Applied Science Publishing 2013-10 /pmc/articles/PMC3794159/ /pubmed/23876425 http://dx.doi.org/10.1016/j.tins.2013.06.007 Text en © 2013 Elsevier Ltd. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license |
spellingShingle | Opinion Warren, Jason D. Rohrer, Jonathan D. Schott, Jonathan M. Fox, Nick C. Hardy, John Rossor, Martin N. Molecular nexopathies: a new paradigm of neurodegenerative disease |
title | Molecular nexopathies: a new paradigm of neurodegenerative disease |
title_full | Molecular nexopathies: a new paradigm of neurodegenerative disease |
title_fullStr | Molecular nexopathies: a new paradigm of neurodegenerative disease |
title_full_unstemmed | Molecular nexopathies: a new paradigm of neurodegenerative disease |
title_short | Molecular nexopathies: a new paradigm of neurodegenerative disease |
title_sort | molecular nexopathies: a new paradigm of neurodegenerative disease |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794159/ https://www.ncbi.nlm.nih.gov/pubmed/23876425 http://dx.doi.org/10.1016/j.tins.2013.06.007 |
work_keys_str_mv | AT warrenjasond molecularnexopathiesanewparadigmofneurodegenerativedisease AT rohrerjonathand molecularnexopathiesanewparadigmofneurodegenerativedisease AT schottjonathanm molecularnexopathiesanewparadigmofneurodegenerativedisease AT foxnickc molecularnexopathiesanewparadigmofneurodegenerativedisease AT hardyjohn molecularnexopathiesanewparadigmofneurodegenerativedisease AT rossormartinn molecularnexopathiesanewparadigmofneurodegenerativedisease |